Managers hedged budgets, leaving capital frozen. AI agents now reallocate funds in real time, freeing €1B for new discoveries.
A global biopharmaceutical company faces massive R&D risks, where a single Phase III trial costs $500 million despite a 35% chance of failure.
High attrition rates meant 90% of Phase I candidates failed, wasting years of development time. Additionally, defensive internal hedging during...
“Last year, I redeployed close to a billion euros in real time. We didn’t wait for a budget cycle; we had real-time business intelligence. Using AI, we reduced out-of-stocks by 80 percent, which is close to a billion euros, and we improved asset utilization by more than ten percentage points.”
Biopharmaceutical company specializing in immunology, vaccines, and rare diseases.
Provided agentic AI and LLM technology for Sanofi's end-to-end business transformation.
Worked as an ecosystem partner to help Sanofi accelerate drug discovery and development via AI.
Related implementations across industries and use cases
Teams reactively managed trials across scattered systems. AI now integrates data to predict bottlenecks and recommend interventions.
Clinical teams spent hours manually compiling siloed data. Now, AI agents query those systems to deliver trial insights in minutes.
Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.
Teams reactively managed trials across scattered systems. AI now integrates data to predict bottlenecks and recommend interventions.
Clinical teams spent hours manually compiling siloed data. Now, AI agents query those systems to deliver trial insights in minutes.
Attorneys juggled fragmented tools to search 50,000 cases. An AI orchestrator now routes queries to sub-agents in a single chat.
Scattered data slowed prep for 15-minute visits. AI now fuses insights into instant briefs, saving reps one full day of admin weekly.
Analysts struggled to track trends across scattered sources. AI now expands queries to catch every patent and press release instantly.
Scattered manual research slowed high-stakes answers. GenAI now cuts analysis from weeks to minutes for 13,000 employees.